Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?

Open Access

Review articles synthesize the best available evidence on a topic relevant to the pathogens community.

Tom H. M. Ottenhoff ,

* E-mail: t.h.m.ottenhoff@lumc.nl

Affiliation Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands
⨯
Stefan H. E. Kaufmann

Affiliation Deptartment of Immunology, Max Planck Institute for Infection Biology, Berlin, Germany
⨯

Reader Comments (0)

Mycobacterium tuberculosis
Is the Subject Area "Mycobacterium tuberculosis" applicable to this article?

Thanks for your feedback.
Tuberculosis
Is the Subject Area "Tuberculosis" applicable to this article?

Thanks for your feedback.
T cells
Is the Subject Area "T cells" applicable to this article?

Thanks for your feedback.
Vaccine development
Is the Subject Area "Vaccine development" applicable to this article?

Thanks for your feedback.
HIV vaccines
Is the Subject Area "HIV vaccines" applicable to this article?

Thanks for your feedback.
Immune response
Is the Subject Area "Immune response" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Tuberculosis drug discovery
Is the Subject Area "Tuberculosis drug discovery" applicable to this article?

Thanks for your feedback.